Abviris Home

Tumor marker

A blood based entire body screen to find HPV induced cancer early - all within minutes and by using just one drop of blood

Prevo-Check®

Rapid test for detecting HPV16 induced carcinomas early. Easy to use in doctor's practice.
Clinical specificity > 99%

White Papers

Learn more about screening for HPV induced cancer in the white paper series "Guidelines for identifying high-risk patients"

Online Courses

Interactive training resources on early detection of HPV-induced carcinomas

previous arrow
next arrow
Slider

Moving from cell to blood based HPV cancer screening.

Abviris offers a new patented generation of Immune Oncology Diagnostics for early detection of HPV induced cancer, allowing a blood based entire body screen within minutes just using one drop of blood.

Learn more about Prevo-Check®

News

Biotech innovator Abviris appoints new leader to drive business expansion

NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: jennie@carverwilde.com   FOR IMMEDIATE RELEASE   Biotech innovator Abviris appoints new leader to drive business expansion Diagnostics industry expert Dr Roman Niedbal joins as CEO   AHRENSBURG, Germany (December 16, 2020) –Abviris Deutschland GmbH has appointed …

‘Pinprick’ biomarker blood test offers diagnostic potential in HPV-related cancers

NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: jennie@carverwilde.com   FOR IMMEDIATE RELEASE ‘Pinprick’ biomarker blood test offers diagnostic potential in HPV-related cancers Study shows rising antibody levels predict the course of cancer   AHRENSBURG, Germany (November 10, 2020) – A potential breakthrough in …

AND THE WINNER IS…

Abviris Deutschland GmbH has been awarded “Pilot of the Year“ by the UK Diagnostics Summit 2019. This prestigious award was presented at the summit on 28 November 2019 in Manchester. High-ranking representatives of the National Health Service (NHS), diagnostics industry and the British IVD Association (BIVDA) honoured the results of a pilot study into the …

Events

  • 51st DDG conference

    Visit us during this online conference and learn more about Prevo-Check(R): a blood-based tumour marker point of care test for HPV-associated cancers of the mouth, throat, anal and genital areas.

    April 14 - April 17

  • 92nd annual ENT conference

    Visit us at our booth and learn more about HPV-induced tumours in the oropharynx and how to detect them early. Organiser: Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgi...

    May 12 - May 15

  • EUROGIN 2021

    We look forward to welcoming you to the Abviris stand in location A1.

    May 30 - June 1

View all events